相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Michael J. Seckl et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Characterization of simvastatin acid uptake by organic anion transporting polypeptide 3A1 (OATP3A1) and influence of drug-drug interaction
Amandla Atilano-Roque et al.
TOXICOLOGY IN VITRO (2017)
Molecular mechanisms of statin intolerance
Anna Gluba-Brzozka et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
Statin Intolerance: A Literature Review and Management Strategies
David R. Saxon et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Intermediate Filaments: Structure and Assembly
Harald Herrmann et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Vimentin Intermediate Filaments Template Microtubule Networks to Enhance Persistence in Cell Polarity and Directed Migration
Zhuo Gan et al.
CELL SYSTEMS (2016)
Intermediate Filaments as Organizers of Cellular Space: How They Affect Mitochondrial Structure and Function
Nicole Schwarz et al.
CELLS (2016)
Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study
Chris R. Cardwell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Statin Intolerance
David H. Fitchett et al.
CIRCULATION (2015)
Intermediate filament structure: the bottom-up approach
Anastasia A. Chernyatina et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S. Stroes et al.
EUROPEAN HEART JOURNAL (2015)
Mitochondrial membrane potential is regulated by vimentin intermediate filaments
Ivan S. Chernoivanenko et al.
FASEB JOURNAL (2015)
Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function
Jason Lowery et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Microtubule-dependent transport and dynamics of vimentin intermediate filaments
Caroline Hookway et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
Vimentin is involved in regulation of mitochondrial motility and membrane potential by Rac1
Elena A. Matveeva et al.
BIOLOGY OPEN (2015)
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
P. Jiang et al.
BRITISH JOURNAL OF CANCER (2014)
More Than a Billion People Taking Statins? Potential Implications of the New Cardiovascular Guidelines
John P. A. Ioannidis
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Statins and breast cancer prognosis: evidence and opportunities
Thomas P. Ahern et al.
LANCET ONCOLOGY (2014)
The role of distant mutations and allosteric regulation on LovD active site dynamics
Gonzalo Jimenez-Oses et al.
NATURE CHEMICAL BIOLOGY (2014)
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
Katsuhiko Warita et al.
SCIENTIFIC REPORTS (2014)
Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation
Natasha T. Snider et al.
JOURNAL OF CELL BIOLOGY (2013)
Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases
Y. Zhu et al.
CELL DEATH & DISEASE (2013)
Molecular insight in the multifunctional activities of Withaferin A
Wim Vanden Berghe et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Withaferin A Alters Intermediate Filament Organization, Cell Shape and Behavior
Boris Grin et al.
PLOS ONE (2012)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
What is a relevant statin concentration in cell experiments claiming pleiotropic effects?
Linda Bjorkhem-Bergman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
Ganta Vijay Chaitanya et al.
CELL COMMUNICATION AND SIGNALING (2010)
Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition
Melissa G. Mendez et al.
FASEB JOURNAL (2010)
Directed Evolution and Structural Characterization of a Simvastatin Synthase
Xue Gao et al.
CHEMISTRY & BIOLOGY (2009)
Regulation of Rac1 by Simvastatin in Endothelial Cells DIFFERENTIAL ROLES OF AMP-ACTIVATED PROTEIN KINASE AND CALMODULIN-DEPENDENT KINASE KINASE-β
Ruqin Kou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Introducing intermediate filaments: from discovery to disease
John E. Eriksson et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Vimentin supports mitochondrial morphology and organization
Ho Lam Tang et al.
BIOCHEMICAL JOURNAL (2008)
Intermediate filaments: versatile building blocks of cell structure
Robert D. Goldman et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Muscle Injury, Vimentin Expression, and Nonsteroidal Anti-inflammatory Drugs Predispose to Cryptic Group A Streptococcal Necrotizing Infection
Stephanie M. Hamilton et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin
Paola Bargagna-Mohan et al.
CHEMISTRY & BIOLOGY (2007)
Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin
B. A. Schick et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases
Jessica P. Alexander et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Group A streptococcal myonecrosis:: Increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes
AE Bryant et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments
JE Eriksson et al.
JOURNAL OF CELL SCIENCE (2004)
分享论文
